• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Saturday, June 6, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

Agencies

Aussie scientists find antidote for deadly box jellyfish sting

Published on: May 3, 2019 1:57 AM

Australian researchers believe they have found an antidote to a sting from the world’s most venomous creature, the much-feared box jellyfish.

Researchers at the University of Sydney had been investigating how the venom is so deadly that one box jellyfish can kill 60 people.

The team noticed the venom needs cholesterol to kill human cells and decided to test whether existing drugs could stop it.

“Since there are lots of drugs available that target cholesterol” the team tried one out, said lead author Raymond Lau.

“It worked,” he said. “It’s a molecular antidote.”

Running tests using human cells and mice, the team found it could stop tissue scarring and pain associated with the sting as long as the medicine was injected within 15 minutes.

Stings from box jellyfish — which can be smaller than a fingernail or up to three metres long depending on the species — can cause acute muscular pain, violent vomiting, feelings of “impending doom”, hair that stands on end, strokes, heart failure and death within minutes.

So far they have only tested the sting from the larger, more deadly species.

“We know the drug will stop the necrosis, skin scarring and the pain completely when applied to the skin,” said Associate Professor Neely.

“We don’t know yet if it will stop a heart attack. That will need more research, and we are applying for funding to continue this work.”

The team hopes that eventually a topical cream or spray can be developed to prevent stings that are thought to kill dozens of people each year and hospitalise thousands more.

Filed Under: Infotainment

Submit a Comment




Primary Sidebar




Latest News

The Rock responds to viral joke about his shampoo brand

Govt considers tax relief for salons, gyms in Budget 2026-27

Nick Jonas recalls bonding moment with Glen Powell after frightening flight

Russia says it downed hundreds of drones launched by Ukraine in major wave

Two killed in firing incident at PML-N rally in Gilgit-Baltistan

Pakistan

Two killed in firing incident at PML-N rally in Gilgit-Baltistan

PESCO approves one-month salary bonus for employees

Punjab braces for hotter weather as temperatures climb

Pakistan, Russia agree to boost cooperation against illegal immigration

Pakistan rejects India’s comments on Gilgit-Baltistan elections

More Posts from this Category

Business

SBP’s ‘Go Cashless’ campaign saw Rs 34bn in digital transactions on Eid

Short-term inflation down by 0.56%

Saudi-Pak Business Council shows interest in infrastructure investment

‘Govt, allies united in efforts to craft people-centric budget’

Rupee records gain against US dollar

More Posts from this Category

World

Russia says it downed hundreds of drones launched by Ukraine in major wave

US says Iran launched missiles toward Kuwait and Bahrain

Cockroach Party founder leads protest in Delhi

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.